Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading.

EST Syros Pharmaceuticals (SYRS) trading halted, news pendingDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

EST Syros Pharmaceuticals (SYRS) trading resumesDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research ...

Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It ...

Discover the top 5 cars equipped with ADAS Level 2 technology, offering enhanced safety and convenience features. From Kia ...

Kia has already seen over 20,000 interested buyers who have booked themselves brand-new Syros! Here is a look at the premium ...

The Kia Syros is the latest addition to the lineup of cars in India and comes at a starting price of Rs 9 lakh (ex-showroom).

Kia Syros introduces a range of innovative technologies, including a segment-first Over-the-Air (OTA) software update system.

The manual gearbox remains the preferred choice, while a considerable number of buyers opted for the automatic transmission ...

Syros Pharmaceuticals said it plans to wind down its operations, according to a Securities and Exchange Commission filing. The Cambridge, Mass., company said it would proceed with a voluntary ...